Taheri Maryam, Borumandnia Nasrin, Abdi Hamidreza, Kashi Amir H, Nourani Setareh, Sheikholeslami Sogand, Gilvaei Yasamin Maleki, Ziaeefar Pardis, Basiri Abbas
Urology and Nephrology Research Center, Research Institute for Urology and Nephrology, Shahid Beheshti University of Medical Sciences, No. 103, Shahid Jafari (9th Boostan) St., Pasdaran Ave., P.O. Box: 1666663111, Tehran, Iran.
Department of Epidemiology and Biostatistics, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.
BMC Urol. 2025 Jan 28;25(1):18. doi: 10.1186/s12894-024-01679-2.
Medical Expulsive Therapy (MET) has been recommended as an established modality for the treatment of distal ureteral stones due to its clearance rate, pain control, and patient satisfaction while having minimal morbidity in comparison to other urologic interventions. In some studies, a combination of medications has been used, which we assessed in this network meta-analysis (NMA).
We conducted systematic searches in PubMed, Scopus, and Web of Science to identify relevant trials published between 2001 and 2024. We excluded articles that looked at MET for upper ureteral stone passage or after shock wave lithotripsy (SWL). NMA was performed to compare the effect of combination MET on stone expulsion rate (SER), stone expulsion time (SET), and need for analgesia.
We included 19 studies with 2414 participants. NMA results revealed that the combination MET of α-blockers with PDE-5 inhibitors (OR = 2.7, CI = 1.80,4.05), corticosteroids (OR = 2.7, CI = 1.81,4.13), and phytotherapy (OR: 3.10, CI = 1.62,5.92) were more effective than α-blockers alone in SER. The combination MET of α-blockers with PDE-5 inhibitors (MD: -3.8, CI=-7.0, -0.5) showed significantly lower SET compared to α-blockers alone. Finally, combination MET of α-blockers with PDE-5 inhibitors (MD:1.0, CI = 0.4,1.7) and nifedipine with corticosteroids (MD:1.2, CI = 0.4,1.9) showed a significant decrease in analgesia use.
The combination MET of α-blockers with PDE-5 inhibitors, corticosteroids, and phytotherapy increases the rate of stone clearance 2.7 to 3.1 times more than α-blockers alone. The other benefits of combination MET were lower expulsion time and less analgesia use that needs further studies.
药物排石疗法(MET)因其结石清除率、疼痛控制和患者满意度,且与其他泌尿外科干预措施相比发病率极低,已被推荐作为治疗远端输尿管结石的既定方法。在一些研究中,使用了联合用药,我们在这项网络荟萃分析(NMA)中对其进行了评估。
我们在PubMed、Scopus和科学网进行了系统检索,以识别2001年至2024年期间发表的相关试验。我们排除了研究输尿管上段结石排石或冲击波碎石术(SWL)后MET的文章。进行NMA以比较联合MET对结石排出率(SER)、结石排出时间(SET)和镇痛需求的影响。
我们纳入了19项研究,共2414名参与者。NMA结果显示,α受体阻滞剂与磷酸二酯酶5抑制剂联合使用的MET(OR = 2.7,CI = 1.80,4.05)、皮质类固醇(OR = 2.7,CI = 1.81,4.13)和植物疗法(OR:3.10,CI = 1.62,5.92)在SER方面比单独使用α受体阻滞剂更有效。与单独使用α受体阻滞剂相比,α受体阻滞剂与磷酸二酯酶5抑制剂联合使用的MET(MD:-3.8,CI = -7.0,-0.5)的SET显著更低。最后,α受体阻滞剂与磷酸二酯酶5抑制剂联合使用的MET(MD:1.0,CI = 0.4,1.7)以及硝苯地平与皮质类固醇联合使用的MET(MD:1.2,CI = 0.4,1.9)显示镇痛药物使用显著减少。
α受体阻滞剂与磷酸二酯酶5抑制剂、皮质类固醇和植物疗法联合使用的MET使结石清除率比单独使用α受体阻滞剂提高2.7至3.1倍。联合MET的其他益处是排出时间更短和镇痛药物使用更少,这需要进一步研究。